LGALS9 and neoplasm: In addition, we found that tumor-associated CD8+ T cells expressed a higher level of T-cell immunoglobulin domain and mucin domain-3 (TIM-3, the receptor of galectin-9) than non-tumor CD8+ T cells (Figure 4B).